STOCK TITAN

Evaxion (EVAX) CFO Form 3/A details share and warrant stakes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3/A

Rhea-AI Filing Summary

Evaxion A/S Chief Financial Officer Thomas Frederik Schmidt has amended his initial statement of beneficial ownership to update his equity holdings. The filing shows direct ownership of 645,750 ordinary shares and warrants that are exercisable into 322,850 ordinary shares at an exercise price of $0.0590 per share.

The warrants relate to a public offering that closed on January 31, 2025 and expire on January 31, 2030. The Form 3/A records these positions as holdings rather than new purchases or sales, giving a snapshot of his current direct stake in Evaxion.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Schmidt Thomas Frederik

(Last)(First)(Middle)
DR. NEERGAARDS VEJ 5F

(Street)
HORSHOLMDK-2970

(City)(State)(Zip)

DENMARK

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Evaxion A/S [ EVAX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares645,750D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants(1)01/31/202501/31/2030Ordinary Shares322,850$0.059D
Explanation of Responses:
1. Warrants pursuant to public offering that closed 1/31/2025.
Remarks:
Exhibit List - Exhibit 24.1 Power of Attorney. This Form 3/A amends the Form 3 filed on March 18, 2026, which reported Mr. Schmidt's initial holdings using the Issuer's CIK number as an interim measure, pending receipt of Mr. Mr. Schmidt's new filer CIK codes. This Form 3/A has been filed using Mr. Schmidt's CIK codes and reflects him as the Reporting Owner, with no alteration to his beneficial ownership.
/s/ Michael Baird, Attorney-in-Fact03/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Evaxion (EVAX) Form 3/A filing by the CFO report?

The Form 3/A shows updated beneficial ownership for Evaxion’s CFO. It lists his direct holdings of ordinary shares and warrants, providing a snapshot of his current equity stake rather than recording new buying or selling activity.

How many Evaxion (EVAX) ordinary shares does the CFO directly hold in this Form 3/A?

The CFO is reported as directly holding 645,750 ordinary shares. This count reflects his position after any prior transactions, serving as an updated baseline of his direct share ownership in Evaxion A/S at the time of the filing.

What warrant position is disclosed for the Evaxion (EVAX) CFO in the Form 3/A?

The filing lists warrants exercisable into 322,850 ordinary shares. These warrants carry an exercise price of $0.0590 per share and provide additional potential equity exposure for the CFO if exercised before their stated expiration date.

When do the Evaxion (EVAX) CFO’s warrants expire and what offering are they from?

The warrants expire on January 31, 2030 and are tied to a public offering that closed on January 31, 2025. A footnote clarifies this origin, linking the derivative position to that specific capital markets transaction.

Does the Evaxion (EVAX) CFO Form 3/A indicate any new share purchases or sales?

The Form 3/A records holdings rather than new trades. Both the ordinary shares and warrants are shown as positions after the reported date, with transaction fields indicating no classified buys or sells in this particular amendment.
Evaxion AS

NASDAQ:EVAX

View EVAX Stock Overview

EVAX Rankings

EVAX Latest News

EVAX Latest SEC Filings

EVAX Stock Data

29.94M
6.88M
Biotechnology
Healthcare
Link
Denmark
Horsholm